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ABSTRACT: Mycobacterium tuberculosis (Mtb) produces a number of sulfur-containing metabolites that
contribute to its pathogenesis and ability to survive in the host. These metabolites are products of the
sulfate assimilation pathway. CysQ, a 3′-phosphoadenosine-5′-phosphatase, is considered an important
regulator of this pathway in plants, yeast, and other bacteria. By controlling the pools of 3′-
phosphoadenosine 5′-phosphate (PAP) and 3′-phosphoadenosine 5′-phosphosulfate (PAPS), CysQ has
the potential to modulate ﬂux in the biosynthesis of essential sulfur-containing metabolites. Bioinformatic
analysis of the Mtb genome suggests the presence of a CysQ homologue encoded by the gene RV2131c.
However, a recent biochemical study assigned the protein’s function as a class IV fructose-1,6-
bisphosphatase. In the present study, we expressed RV2131c heterologously and found that the protein
dephosphorylates PAP in a magnesium-dependent manner, with optimal activity observed between pH
8.5 and pH 9.5 using 0.5 mM MgCl2. A sensitive electrospray ionization mass spectrometry-based assay
was used to extract the kinetic parameters for PAP, revealing a Km (8.1 ( 3.1 µM) and kcat (5.4 ( 1.1
s-1) comparable to those reported for other CysQ enzymes. The second-order rate constant for PAP was
determined to be over 3 orders of magnitude greater than those determined for myo-inositol 1-phosphate
(IMP) and fructose 1,6-bisphosphate (FBP), previously considered to be the primary substrates of this
enzyme. Moreover, the ability of the RV2131c-encoded enzyme to dephosphorylate PAP and PAPS in
ViVo was conﬁrmed by functional complementation of an Escherichia coli ∆cysQ mutant. Taken together,
these studies indicate that RV2131c encodes a CysQ enzyme that may play a role in mycobacterial sulfur
metabolism.
Tuberculosis poses a critical threat to global health. It is
estimated that one-third of the world’s population is infected
with Mycobacterium tuberculosis (Mtb),
1 the disease-causing
bacterium (1). The emergence of drug-resistant strains has
rapidly diminished the efﬁcacy of current antibiotics, urging
the development of more effective treatments and the
identiﬁcation of new therapeutic targets (2, 3).
Many sulfur-containing metabolites have been implicated
in Mtb pathogenesis, suggesting the sulfate assimilation
pathway may serve as a reservoir of molecules intimately
linked to the virulence and survival of the bacterium (4, 5).
Notable examples include sulfolipid-1, a glycolipid constitu-
ent of the Mtb cell wall that has been correlated with
virulence (6), and mycothiol, an abundant low molecular
mass thiol whose antioxidant activity may facilitate bacterial
survival in the host (7-9). In addition, disruption of the
reductive branch of the sulfate assimilation pathway has been
shown to attenuate Mtb virulence and persistence during the
chronic phase of infection in mice (10). Genes involved in
the sulfate assimilation pathway are frequently upregulated
under conditions that mimic the latent stage of the Mtb life
cycle; some of these genes lack a human counterpart, making
them attractive drug targets (4, 11, 12). Since dormant
mycobacteria are impervious to antibiotics which rely on
active cell division, the machinery used by these bacteria in
the metabolism of sulfur may represent new targets for
therapeutic intervention.
The sulfate assimilation pathway of Mtb is analogous to
the prototypical pathway of Escherichia coli (Figure
1) (13-15). It begins with the uptake of inorganic sulfate,
which is subsequently activated by condensation with ATP
in a reaction catalyzed by ATP sulfurylase. This enzyme,
encoded by the genes cysD and cysN, is a heterodimeric
G-protein that couples GTP hydrolysis with the sulfurylation
of ATP to generate adenosine 5′-phosphosulfate (APS). APS
is then phosphorylated at the 3′-position by APS kinase
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In E. coli, this intermediate is reduced to sulﬁte and
3′-phosphoadenosine 5′-phosphate (PAP) by PAPS reductase
(CysH), which uses thioredoxin as an electron donor. Sulﬁte
is then reduced to sulﬁde, which is incorporated into several
reduced sulfur-containing metabolites, such as cysteine,
methionine, and mycothiol, by other enzymes in the Cys
regulon. In Mtb, however, this reduction cascade emanates
from APS, which is reduced to sulﬁte by APS reductase (also
termed CysH) (15, 16). This leaves PAPS to serve as the
sulfuryl group donor for a set of eukaryotic-like sulfotrans-
ferases, which generate sulfated metabolites believed to
mediate host-pathogen interactions and signaling pathways
in the bacterium (17-19).
One regulator of sulfate assimilation in E. coli is the
phosphatase CysQ (20, 21). Mutations in the cysQ gene result
in cysteine and sulﬁte auxotrophy under aerobic conditions,
which supports a key role for this enzyme in sulfur
metabolism. CysQ is believed to regulate the intracellular
level of PAPS, which may be cytotoxic at high concentra-
tions (20, 22). In addition, CysQ is thought to modulate PAP
levels in the cell (22, 23), an activity that might further
regulate the biosynthesis of reduced sulfur-containing me-
tabolites since PAP is a competitive inhibitor of PAPS
reductase. Interestingly, PAP accumulation negatively regu-
lates the activity of other important bacterial enzymes (24).
Examples include oligoribonuclease, an exonuclease which
degrades small ribonucleotides, and phosphopantetheinyl-
transferase, an enzyme which transfers the 4-phosphopan-
tetheine group of coenzyme A to acyl carrier protein during
fatty acid biosynthesis and the production of secondary
metabolites (25). Thus, CysQ may not only regulate the cell’s
ability to metabolize sulfur but could also play a role in other
essential bacterial processes. Yet, no homologue of the E.
coli CysQ has been characterized in Mtb.
Given the many parallels between sulfur metabolism in
E. coli and Mtb, we reasoned that a CysQ-like phosphatase
could be functional in mycobacteria. Upon searching the Mtb
genome, we discovered a gene, RV2131c, whose encoded
protein shares 31% amino acid sequence identity with the
E. coli CysQ (26). However, a recent report by Gu and co-
workers (27) indicated the encoded enzyme may serve as a
bifunctional inositol monophosphatase and fructose-1,6-
bisphosphatase, a ﬁnding that supports a role for RV2131c
in myo-inositol biosynthesis and challenges its assignment
to the mycobacterial sulfate assimilation pathway.
Here, we clarify the physiological role of RV2131c by
providing conclusive evidence that the gene product can
function as a CysQ phosphatase. Genetic complementation
of an E. coli ∆cysQ mutant with the Mtb gene unequivocally
establishes its ability to dephosphorylate PAP and PAPS in
ViVo. In addition, following the heterologous expression of
RV2131c in E. coli, the enzyme was puriﬁed and character-
ized to obtain kinetic parameters for PAP, myo-inositol
1-phosphate (IMP), and fructose 1,6-bisphosphate (FBP). The
data conﬁrm that PAP is the preferred in Vitro substrate of
RV2131c, redeﬁning the substrate speciﬁcity of this enzyme
and validating its assignment as a CysQ phosphatase. Taken
together, these ﬁndings suggest that RV2131c may serve as
an important regulator of sulfur metabolism in Mtb. With
the potential to manipulate sulfation levels in the cell and
regulate the biosynthesis of essential reduced sulfur-contain-
ing metabolites, CysQ may be an attractive target for
antibiotic therapy.
EXPERIMENTAL PROCEDURES
Materials. Pfu DNA polymerase was from Stratagene (La
Jolla, CA). Oligonucleotides were from Elim Biopharma-
ceuticals, Inc. (Hayward, CA). Restriction enzymes and calf
intestinal alkaline phosphatase (CIP) were from New England
Biolabs (Ipswich, MA). Qiagen kits were used for plasmid
DNA puriﬁcation and the extraction of DNA from agarose
gels. T4 DNA ligase and BL21(DE3) chemically competent
cells were purchased from Invitrogen (Carlsbad, CA).
Vectors were obtained from Novagen (pET28b; Madison,
WI) and the American Type Culture Collection (pBAD18;
FIGURE 1: Sulfate assimilation pathways of E. coli and Mtb. Arrows with dotted lines designate enzymatic reactions speciﬁc to E. coli.
Bolded arrows designate those speciﬁc to Mtb.
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Biopharmaceuticals, Inc. All chemicals were purchased from
Sigma-Aldrich (St. Louis, MO) and were used without further
puriﬁcation, including 3′-phosphoadenosine 5′-phosphate
(PAP), guanosine 5′-monophosphate (GMP), adenosine 5′-
monophosphate (AMP), D-myo-inositol 1-monophosphate
(IMP), and D-fructose 1,6-bisphosphate (FBP). Assay mix-
tures were prepared in water that was doubly distilled and
deionized using a Milli-Q system (Millipore; Billerica, MA).
All other materials used in this work were obtained from
sources cited within the text.
Preparation of Expression Vector. The RV2131c gene was
PCR-ampliﬁed from Mtb H37Rv genomic DNA with the
primers 5′-TTACGTAGGACATATGGTGGTGAGCCCT-
GCCGCACC-3′ (NdeI) and 5′-TAGTATAAGCGGATCCT-
CAGCGCCACGCGTCGGCGA-3′ (BamHI). The resulting
0.8 kilobase fragment was digested with NdeI and BamHI
and ligated into a similarly digested and CIP-treated pET28b
vector with an N-terminal His6 tag. DNA sequencing was
used to conﬁrm the successful construction of the pET28b_
2131c plasmid.
Preparation of E. coli Complementation Vector. The
RV2131c gene was PCR-ampliﬁed from Mtb H37Rv genomic
DNA with the primers 5′-CACAGTTACGTCTAGAAG-
GAGGTACTGAATGGTGAGCCCTGCCGCAC-3′ (XbaI)
and 5′-ACATGACTCTAAGCTTTCAGCGCCACGCGT-
CGGCGA-3′ (HindIII). A ribosome binding site was added
by PCR and is shown in boldface type. The PCR product
was digested with XbaI and HindIII and ligated into a
similarly digested and CIP-treated pBAD18 vector with an
ampicillin resistance marker and an arabinose-inducible
promoter (28). DNA sequencing was used to conﬁrm the
successful construction of the pBAD18_2131c plasmid.
Expression of RV2131c in E. coli. pET28b_2131c was
transformed into E. coli strain BL21(DE3). Transformants
were used to inoculate 1 L cultures of LB medium containing
50 mg/L kanamycin, which were incubated at 37 °C for
approximately 2.5 h with shaking until an OD600 of 0.6-0.8
was reached. Protein expression was induced by the addition
of isopropyl  -D-thiogalactoside (IPTG) to a ﬁnal concentra-
tion of 100 µM. The cultures were grown for an additional
2 0ha t1 8°C before the cells were harvested by centrifuga-
tion (6000 rpm, 4 °C, 15 min). The collected cells (∼5 g/L)
were suspended in 20 mL of PAP-agarose buffer (50 mM
Tris buffer, pH 7.5, 10 mM CaCl2, and 50 mM KCl)
supplemented with 5 µg/mL lysozyme, 5 µg/mL DNase, and
1 complete, EDTA-free protease inhibitor cocktail tablet
(Roche) at 4 °C. Cells were lysed by ultrasonication (Misonix
Sonicator 3000) or using a high-pressure homogenizer
(Avestin EmulsiFlex-C5). The cell lysate was cleared by
centrifugation (18500 rpm, 4 °C, 20 min), and the protein
was puriﬁed from the supernatant as previously described
(21). Brieﬂy, ∼1.5 mL of PAP-agarose resin (Sigma) was
swelled in PAP-agarose buffer and added to the supernatant,
which was rocked gently with the beads for2ha t4°C.
The supernatant was applied to a chromatography column
and collected by gravity ﬂow. The resin was washed with
20 mL of PAP-agarose buffer containing 500 mM NaCl,
followed by 20 mL of PAP-agarose buffer. To elute the
protein, 3 mL of elution buffer (PAP-agarose buffer contain-
ing 300 µM PAP) was allowed to equilibrate with the column
for 20 min before 0.5 mL fractions were collected.
SDS-PAGE was used to identify column fractions contain-
ing the desired protein, which were concentrated and further
puriﬁed by size exclusion chromatography. The protein was
loadedontoaHiPrep16/60SephacrylS-300highresolution-gel
ﬁltration column (GE Healthcare Biosciences Corp.) equili-
brated with gel ﬁltration buffer (50 mM Tris buffer, pH 7.5,
10% glycerol, 1 mM dithiothreitol). Fractions (2 mL each)
were analyzed by SDS-PAGE, and those containing pure
protein were concentrated by centrifugation and stored at
-80 °C.
To conﬁrm the protein’s identity, the puriﬁed sample was
desalted on a microbore reversed-phase column (Bruker
Agilent) and characterized using a Bruker Hewlett-Packard
ESI-ion trap mass spectrometer. Tryptic digestion and mass
ﬁngerprinting using an Applied Biosystems 4800 MALDI-
TOF were used to provide further conﬁrmation of the
protein’s identity. Protein concentration was determined by
UV absorption at 280 nm using a calculated extinction
coefﬁcient of 46350 M-1 cm-1.
ActiVity Assays. The Baykov malachite green method (29)
was used to establish phosphatase activity with PAP as the
substrate and to determine the optimal conditions for
catalysis. A standard reaction mixture contained 50 mM Tris
buffer, pH 8.5, 100 µM PAP, 0.5 mM MgCl2,a n d5n M
enzyme in a 200 µL volume. The reaction was preincubated
for 5 min at 30 °C prior to the addition of enzyme and
quenched 5 min thereafter by adding one-fourth volume of
acidic malachite green dye solution. After 10 min, the
absorbance of the reaction at 630 nm was determined using
a Molecular Devices SpectraMax 190 UV-visible plate
reader. A standard curve generated using monobasic potas-
sium phosphate was used to correlate the absorbance of the
reaction mixture with the concentration of inorganic phos-
phate in solution. Since enzyme activity was determined to
be linear under these reaction conditions, the initial rate of
the reaction was calculated by dividing the concentration of
liberated phosphate by the reaction time. Control reactions
without enzyme were treated identically and used to account
for background hydrolysis of the substrate. For the deter-
mination of the optimum pH range, metal cofactor, and
MgCl2 concentration, the corresponding factors were varied.
To evaluate the effect of various alkali metal cations on
enzyme activity, increasing amounts of each cation were
added to the standard reaction mixture.
Enzyme Kinetics. The kinetic parameters for PAP were
determined using a previously described electrospray ioniza-
tion mass spectrometry (ESI-MS) assay (30, 31) with some
modiﬁcations, as described below.
Mass Spectrometry. Mass spectra were acquired using a
quadrupole time-of-ﬂight (Q-Tof) mass spectrometer equipped
with a Z-spray electrospray ionization (ESI) source (Q-Tof
Premier; Waters, Beverly, MA). Sample solutions were
infused from a 250 µL gastight syringe (Hamilton, Reno,
NV) into the ESI probe at a ﬂow rate of 5 µL/min using a
syringe pump. The electrospray was emitted from a stainless
steel capillary with an inner diameter of 127 µm. The ion
source parameters were as follows: ESI capillary voltage 2.4
kV, nebulizing gas (nitrogen) ﬂow rate 800 L/h, sample cone
voltage 35 V, extraction cone and ion guide voltages 5 V,
source block temperature 80 °C, and nebulizing gas tem-
perature 200 °C. No cone gas was used. The pressures in
the different stages of the instrument were as follows: ﬁrst
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quadrupole analyzer 2 × 10-5 mbar, argon-ﬁlled cell 8 ×
10-3 mbar, and Tof analyzer 9 × 10-7 mbar. The Tof
analyzer was operated in “V” mode. Under these conditions,
a mass resolving power (32) of 10000 was routinely
achieved. For each sample, mass spectra were recorded in
the negative ion mode for a period of 4 min. The electrospray
emitter was rinsed with deionized water after each measure-
ment to avoid cross-contamination between samples. External
mass calibration was performed immediately prior to mea-
surements using solutions of sodium formate. Mass spectra
were processed using MassLynx software (version 4.1;
Waters).
Single-Point Normalization Factor. Guanosine 5′-mono-
phosphate (GMP) was selected as the internal standard due
to its structural similarities to the product of PAP dephos-
phorylation, AMP. A solution containing 5 µM AMP in 50
mM Tris buffer, pH 8.5, and 0.5 mM MgCl2 was prepared.
A2 5µL aliquot of the solution was mixed with 100 µLo f
water containing 6.25 µM GMP. The intensities of the
product ion (IP) and internal standard ion (IIS) measured by
ESI-MS were used to obtain the corresponding single-point
normalization factor R. R relates the intensity ratio, IP/IIS,t o
the concentration ratio of the respective analytes as described
in eq 1.
R)(IP/IIS)/([product]/[internal standard]) (1)
Equation 1 can be rearranged to calculate the product
concentration when R, IP/IIS, and the concentration of the
internal standard are known (eq 2). If the initial rate of a
reaction is desired, the product concentration can be divided
by the reaction time (TR) provided that enzyme activity is
linear during that time (eq 3).
[product])(IP/IIS)[internal standard]/R (2)
V0)[product]/TR (3)
Reaction Progress CurVe. To establish the linear range
of PAP phosphatase activity, a reaction progress curve was
generated. A 421 µL reaction mixture containing 50 mM
Tris buffer, pH 8.5, 0.5 mM MgCl2, and 25 µM PAP was
preincubated for 5 min at 30 °C. Prior to the addition of
enzyme, a 25 µL aliquot was removed and quenched with 5
µL of 10% HCl to obtain a 0 min time point. To initiate the
reaction, 4 µL of a 500 nM enzyme stock was added to
the mixture for a ﬁnal enzyme concentration of 5 nM. The
reaction proceeded at 30 °C for 30 min, during which 25
µL aliquots were removed and quenched as described above.
A2 5µL aliquot from each quenched sample was then mixed
with 100 µL of internal standard solution (6.25 µM GMP in
water) and analyzed by ESI-MS. The concentration of AMP
in each sample was calculated as described above and used
to determine the extent of substrate conversion as a function
of time.
Determination of Michaelis-Menten Parameters for PAP.
Attempts to characterize the kinetic parameters for PAP using
the malachite green assay suggested that the Km was below
20 µM (data not shown). Because this is near the detection
limit of the assay, a more sensitive method was required for
the kinetic analysis of this substrate. Eight reaction mixtures
(198 µL each) containing 50 mM Tris buffer, pH 8.5, 0.5
mM MgCl2, and a variable concentration of PAP (0.625-50
µM) were prepared. Following a 5 min incubation at 30 °C,
the reactions were initiated by adding 2 µL of a 500 nM
enzyme stock for a ﬁnal enzyme concentration of 5 nM. After
4 min at 30 °C, the reactions were quenched using 40 µLo f
10% HCl. Samples for ESI-MS analysis were prepared by
combining 25 µL of each quenched reaction with 100 µLo f
internal standard solution. Using the calculated AMP con-
centration for each sample, the corresponding initial rates
were determined and plotted against PAP concentration using
KaleidaGraph (version 4.03) to obtain Michaelis-Menten
parameters.
Determination of Michaelis-Menten Parameters for IMP
and FBP. The kinetic parameters for IMP and FBP were
determined using the malachite green assay (29). Reaction
mixtures were prepared using the optimal conditions for
catalysis reported previously for these substrates (27).
Mixtures containing 50 mM Tris buffer, pH 9.0, 10 mM
MgCl2, 110 nM enzyme, and a variable concentration of IMP
(1-5.5 mM) or FBP (90-900 µM) were prepared in a 100
µL volume. The substrate concentrations used in these studies
were based on the previously reported Km values for IMP
(220 µM) and FBP (450 µM) (27). However, initial experi-
ments revealed that the Km for IMP was much greater than
expected, necessitating the use of a higher concentration
range. Because substrate inhibition was observed for both
IMP and FBP, the highest substrate concentrations used in
the kinetic analysis of these substrates were 5.5 mM and
900 µM, respectively. The reactions were preincubated for
5 min at 30 °C prior to the addition of enzyme and quenched
15 min thereafter by adding one-fourth volume of acidic
malachite green dye solution. Enzyme activity was deter-
mined to be in the linear regime under these reaction
conditions. Control reactions without enzyme were used to
account for the background hydrolysis of each substrate. The
amount of inorganic phosphate in each sample was quantiﬁed
as described above and used to determine the initial rates
corresponding to each substrate concentration. KaleidaGraph
was used to determine the kinetic parameters for these
substrates.
Genetic Complementation in E. coli. An E. coli mutant
with a Tn5Kan-I-SceI transposon in the cysQ gene was
obtained from the E. coli Genome Project at the University
of WisconsinsMadison. Cells cultured overnight in 2 mL
of LB medium with 50 mg/L kanamycin were used to
inoculate1Lo fLB/kanamycin medium and grown for
approximately3ha t3 7°C with shaking to an OD600 of
∼0.6. The cells were then cooled to 4 °C and made
electrocompetent by washing them four times, twice in ice-
cold water and twice in ice-cold 10% glycerol, and resus-
pending them in 0.5 mL of 10% glycerol. Electroporation
with a Bio-Rad gene pulser was used to transform plasmid
DNA into the cells following the manufacturer’s protocol.
Transformants were grown on LB agar containing 50 mg/L
kanamycin and 100 mg/L ampicillin. Individual colonies
were streaked onto M9 minimal medium [10 g/L M9 minimal
salts (Sigma), 15 g/L Bacto Agar, 0.2% glycerol, 1 mM
MgSO4, and 0.1 mM CaCl2] containing arabinose (0.2%)
and 50 mg/L kanamycin. Certain plates also contained 100
mg/L ampicillin and/or 0.5 mM Na2SO3. The antibiotics,
MgSO4, CaCl2, arabinose, and Na2SO3 were sterile-ﬁltered
individually and added following autoclave sterilization of
the remaining media. Plates were incubated at 37 °C for 24 h.
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Identiﬁcation of CysQ Homologue RV2131c in the M.
tuberculosis Genome. BLAST analysis was used to identify
a CysQ homologue in M. tuberculosis with 31% amino acid
sequence identity to E. coli CysQ (UniProtKB entry P22255).
The corresponding gene, RV2131c, was annotated as a
“possible monophosphatase cysQ” in the published genome
(26). The encoded protein bears the conserved metal-binding
motif of the phosphomonoesterase protein family (Figure 2),
which includes the Saccharomyces cereVisiae Hal2p (Unit-
ProtKB P32179), a well-characterized 3′-phosphoadenosine-
5′-phosphatase (23, 33, 34).
Heterologous Expression of RV2131c in E. coli. RV2131c
was expressed in E. coli BL21(DE3) with an N-terminal His6
tag. Initial attempts to purify the protein using the Ni2+ IMAC
procedure described by Gu et al. (27) were unsuccessful.
Signiﬁcant impurities were retained following elution of the
protein from the column. To improve the puriﬁcation process,
a substrate-afﬁnity puriﬁcation step was introduced. PAP-
agarose resin preequilibrated with calcium, an inhibitor of
homologous phosphatases, was used to enrich the RV2131c
gene product by preventing hydrolysis of the immobilized
substrate (21). The protein was eluted using an excess of
PAP and further puriﬁed by size exclusion chromatography.
The protein was stable in gel ﬁltration buffer lacking NaCl,
an inhibitor of certain CysQ homologues (35, 36). For this
reason, NaCl was omitted from subsequent activity assays.
SDS-PAGE analysis revealed an apparent molecular mass
of 30 kDa for the puriﬁed protein. Electrospray ionization
mass spectrometry was used to conﬁrm the identity of the
protein, whose measured mass (30578 ( 1 Da) was in
agreement with the predicted molecular mass of the protein
lacking the N-terminal methionine (30578.5 Da). In addition,
tryptic digestion and mass ﬁngerprinting of the puriﬁed
protein sample generated approximately 83% sequence
coverage, providing further conﬁrmation of the protein’s
identity.
Deﬁning Optimal Conditions for PAP Phosphatase ActiV-
ity. Once the puriﬁed RV2131c gene product was found to
dephosphorylate PAP, its activity with the substrate was
measured as a function of pH, various metal ions, and Mg2+
concentration (Figure 3). The pH-dependent activity proﬁle
was determined by calculating the speciﬁc activity of the
enzyme in the presence of 100 µM PAP and 0.5 mM MgCl2
at pH 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, and 10.0. The optimum
pH was found to be between 8.5 and 9.5 (Figure 3A), similar
to that of other CysQ homologues (22, 37).
To determine its divalent metal ion dependence, the
enzyme was assayed with 100 µM PAP in the presence of
50 mM Tris buffer (pH 8.5) and 0.5 mM MgCl2, MnCl2,
CoCl2, CaCl2, FeCl2, ZnCl2, NiCl2, or CuCl2. As anticipated,
the enzyme was most active with Mg2+, the preferred
cofactor of the phosphomonoesterase protein family (33).
Mn2+ afforded roughly 50% of the activity observed with
Mg2+, while 40% activity was retained in the presence of
Co2+. Less than 7% activity was observed with the remaining
metal ions (Figure 3B). This trend may be explained by
variations in the pKa of metal-coordinated water, which likely
participates in phosphoryl group transfer (38). The pKa’s of
Mg2+-, Mn2+-, and Co2+-coordinated water are between 10.2
and 11.4, whereas those of water coordinated to the remain-
FIGURE 2: Multiple sequence alignment of enzymes from the phosphomonoesterase protein family. Sequences were aligned using ClustalW,
and shading of conserved residues was performed using Jalview. The underlined residues constitute the conserved metal-binding motif of
the phosphomonoesterase protein family. Abbreviations are as follows: Mtb_Rv2131c, Rv2131c from Mtb (UniProtKB entry P65163);
Ecoli_CysQ, CysQ from E. coli (UniProtKB entry P22255); Scer_Hal2, 3′(2′),5′-bisphosphate nucleotidase from S. cereVisiae (UniProtKB
entry P32179); Osat_RHL, 3′(2′),5′-diphosphonucleoside 3′(2′)-phosphohydrolase from O. satiVa (UniProtKB entry P0C5A3); Ecoli_SuhB,
inositol-1-monophosphatase from E. coli (UniProtKB entry P0ADG4); Ecoli_FBPase, fructose-1,6-bisphosphatase from E. coli (UniProtKB
entry P0A993).
FIGURE 3: pH, metal, and Mg2+ dependence of Rv2131c PAP
phosphatase activity. Rv2131c activity as a function of pH (A),
various divalent metal ions (B), or MgCl2 concentration (C).
Conditions: 100 µM PAP, 50 mM Tris buffer, pH 8.5, 0.5 mM
MgCl2, 5 nM enzyme, 30 °C. For (A) through (C), the correspond-
ing conditions were varied. Activities are expressed as a percentage
of the maximum observed activity. These data represent the average
of three independent experiments. Error bars indicate the corre-
sponding standard deviation.
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(39). The microenvironment deﬁned by the enzyme’s active
site appears to favor hydrolysis by water with a pKa that
falls within this narrow range.
Once Mg2+ was identiﬁed as the optimal metal cofactor
for PAP phosphatase activity, different concentrations of the
metal ion (from 0 to 15 mM) were assayed in the presence
of 100 µM PAP and 50 mM Tris buffer (pH 8.5). Maximal
activity was observed with 0.5 mM MgCl2, comparable to
the E. coli CysQ and related enzymes (22, 37, 40). Only a
small amount of the metal ion was needed to activate the
enzyme, which maintained signiﬁcant activity at higher Mg2+
concentrations, though a gradual decline in activity was
observed above 1 mM MgCl2 (Figure 3C).
SensitiVity of RV2131c to Alkali Metal Cations. Proteins
belonging to the phosphomonoesterase protein family are
universally inhibited by lithium, often at submillimolar
concentrations (33). In addition, the PAP phosphatase activity
of CysQ homologues is commonly affected by two other
alkali metal cations: Na+ and K+ (22, 23, 34). Some enzymes
are inhibited by both of these cations (36, 37), whereas others
are inhibited by sodium but activated by potassium (22, 23).
It is likely that the variable cation sensitivity of CysQ
homologues results from structural differences in their alkali
metal-binding sites (34).
To evaluate the sensitivity of the RV2131c-encoded
enzyme to these cations, PAP phosphatase activity was
measured using 100 µM PAP in the presence of 50 mM Tris
buffer (pH 8.5), 0.5 mM MgCl2, and various concentrations
of LiCl (0-10 mM), NaCl (0-500 mM), or KCl (0-500
mM). Lithium was the most potent inhibitor of Rv2131c,
with a half-maximal inhibition concentration (IC50)o f
approximately 0.5 mM (Figure 4). Sodium and potassium
also inhibited PAP hydrolysis but had higher IC50 values (150
and 250 mM, respectively).
ESI-MS Assay. Previous efforts to assay CysQ-type activity
have frequently relied on colorimetric inorganic phosphate
detection or HPLC-based methods (22, 23, 36). However,
the limited sensitivity of these techniques has frustrated
attempts to accurately measure kinetic parameters for
substrates with low micromolar Km values (23, 41). Methods
involving radiolabeled materials have been successfully
employed to obtain the kinetic parameters for such sub-
strates (21, 41) but are often cumbersome. This is especially
true when radioactive substrates must be synthesized due to
a lack of commercial availability, as is the case with PAP.
For these reasons, and because initial attempts to characterize
PAP using the malachite green assay indicated the Km was
below 20 µM, we used a mass spectrometry-based assay for
the steady-state kinetic analysis of this substrate. This
approach has been successfully applied to bacterial sul-
fotransferases, generating kinetic parameters that are in
excellent agreement with those obtained using a radiolabel
transfer assay (30, 31).
To quantify product formation by mass spectrometry, an
internal standard must be used whose mass spectral intensity
can be compared to that of the product ion (30). For this
comparison to be valid, the structure and ionization efﬁciency
of the internal standard must approximate those of the
product. With this in mind, we selected GMP as our internal
standard because of its structural similarities to the PAP
reaction product, AMP. A mixture containing known con-
centrations of AMP and GMP was prepared and analyzed
by ESI-MS to obtain the intensities of the product and
internal standard ions. These values were then used to
calculate a single-point normalization factor R using eq 1.
An average R value of 1.5 ( 0.1 was obtained using a series
of samples prepared and analyzed at different times over a
3 week period. This value was used to calculate the amount
of AMP generated in subsequent assays using eq 2.
Initially, a reaction progress curve was generated to deﬁne
the linear range of enzyme activity (Figure 5). Product
formation was monitored as a function of time by taking
aliquots of a reaction mixture containing 25 µM PAP and 5
nM enzyme over a 30 min period. Each aliquot was quenched
with a 10% HCl solution and then mixed with the internal
standard prior to analysis by ESI-MS. Acid was used to stop
the reaction because the internal standard was not soluble
in methanol, the organic solvent traditionally used as a
quenching agent in this assay (30, 31). The linear portion of
the progress curve was deﬁned between 0 and 6 min with
an R2 value of 0.993 (Figure 5, inset). A reaction time of 4
min was used in subsequent kinetic assays, corresponding
to approximately 37% conversion of substrate to product.
It is noteworthy that unlike previous applications of this
method (30, 31) samples were prepared under entirely
FIGURE 4: Inhibition of Rv2131c PAP phosphatase activity by Li+,
Na+, and K+. Rv2131c activity as a function of LiCl (b), NaCl
(9), or KCl (2) concentration. Conditions: 100 µM PAP, 50 mM
Tris buffer, pH 8.5, 0.5 mM MgCl2, 5 nM enzyme, variable amounts
of LiCl, NaCl, or KCl, 30 °C. Activities are expressed as a
percentage of the activity observed in the absence of monovalent
cations. These data represent the average of three independent
experiments. Error bars indicate the corresponding standard deviation.
FIGURE 5: Reaction progress curve for determining the linear range
of Rv2131c PAP phosphatase activity. Conditions: 25 µM PAP,
50 mM Tris buffer, pH 8.5, 0.5 mM MgCl2, 5 nM enzyme, 30 °C.
The inset shows the linear portion of the curve from 0 to 6 min.
5828 Biochemistry, Vol. 47, No. 21, 2008 Hatzios et al.aqueous conditions and without altering the biochemical
matrix of the reaction. Tris buffer was used at a concentration
of 50 mM in each reaction, demonstrating the ability of this
assay to quantify the products of enzymatic processes in
complex biochemical mixtures. The sensitivity of these
measurements was somewhat limited by the ion suppression
effect of Tris buffer, however, which made it difﬁcult to
obtain accurate reaction progress curves at low substrate
concentrations. For this reason, we were unable to conﬁrm
whether enzyme activity was still linear after 4 min under
these reaction conditions. Thus, the initial rates calculated
at low PAP concentrations may be slightly underestimated
and the Km for this substrate may be even lower than
reported.
Steady-State Kinetic Assays. The kinetics of PAP phos-
phatase activity were measured by reacting various amounts
of substrate with Rv2131c and quantifying product formation
by the ESI-MS assay (Figure S1 of the Supporting Informa-
tion). Reaction velocity was plotted as a function of substrate
concentration (Figure 6), and Michaelis-Menten parameters
were derived using KaleidaGraph.
As anticipated, the Km for PAP is in the low micromolar
range and compares favorably with those of the E. coli CysQ
(1.1 µM) and S. cereVisiae Hal2p (0.72 µM) (Table 1) (21).
These values are consistent with the reportedly low levels
of PAP in the cell (less than 10 µM) (35). The catalytic
efﬁciency of the RV2131c-encoded enzyme for PAP is also
comparable to those of its homologous enzymes (21). The
similar biochemical proﬁles of these enzymes support the
assignment of the RV2131c gene product as a PAP-speciﬁc
phosphatase.
In concurrence with the previous biochemical study of
RV2131c (27), the encoded enzyme was found to dephos-
phorylate IMP and FBP. However, the catalytic efﬁciencies
for these substrates are over 3 orders of magnitude lower
than the corresponding second-order rate constant for PAP,
indicating that PAP is the preferred substrate for Rv2131c.
These ﬁndings suggest the enzyme exhibits only nominal
activity with IMP and FBP in ViVo. While isolated activity
with certain inositol phosphates has been described for a
number of CysQ homologues, PAP is widely deﬁned as the
superior substrate (21, 36, 40-42). The slight promiscuity
of these enzymes can possibly be attributed to the structural
similarities between these substrates and the conservation
of a common metal-binding motif and core fold among
members of the phosphomonoesterase protein family, which
includes various inositol phosphatases, fructose-1,6-bispho-
sphatase, and the E. coli CysQ (33).
PAP phosphatases have also been shown to exhibit activity
with PAPS, another intermediate of the sulfate assimilation
pathway (23, 36, 41, 42). Unfortunately, the phosphosulfate
bond of this substrate is prone to rapid hydrolysis, which
results in conversion to PAP (41, 43). Consequently, the
kinetic analysis of this substrate is complicated by the
presence of a competing substrate. In addition, commercial
PAPS (Sigma, EMD Biosciences) is supplied as a lithium
salt. Since lithium is a potent inhibitor of this enzyme
class (33, 34), ion-exchange chromatography must be used
to purify the substrate prior to its use in biochemical assays.
This puriﬁcation process results in signiﬁcant decomposition
of the compound to PAP and sulfate (41), precluding its
accurate kinetic characterization. For these reasons, attempts
to obtain kinetic parameters for PAPS that would enable a
comparison with the other substrates in this study were
unsuccessful. However, a qualitative assessment of
[35S]PAPS hydrolysis by Rv2131c using thin-layer chroma-
tography and Phosphorimager analysis suggests that PAPS
is a substrate for the enzyme (data not shown).
Genetic Complementation of an E. coli ∆cysQ Mutant.
Given the similarities in sequence and substrate selectivity
between the RV2131c-encoded enzyme and the E. coli CysQ,
we chose to validate the function of RV2131c through genetic
complementation studies in E. coli. A mutant strain of E.
coli lacking CysQ was transformed with RV2131c in a
pBAD18 plasmid under the control of an arabinose-inducible
promoter. Disruption of the cysQ gene in E. coli results in a
growth requirement for sulﬁte or cysteine (Figure 7A) (20).
Thus, following growth on LB agar with ampicillin and
kanamycin, isolated colonies of the transformed cells were
plated onto M9 minimal medium containing sulfate as the
sole sulfur source. Arabinose was also included in the
medium to enable overexpression of the Mtb gene. Comple-
mentation of the mutant strain clearly demonstrated the
ability of the RV2131c gene product to restore prototrophy
in ViVo (Figure 7B). Growth of the mutant strain was restored
to levels observed in the presence of sulﬁte after just 24 h
of growth. Importantly, the vector control maintained cys-
teine and sulﬁte auxotrophy (Figure 7C). These results
support our hypothesis that RV2131c encodes a functional
CysQ in ViVo.
FIGURE 6: Steady-state kinetics of Rv2131c with PAP as the
substrate. A plot of V0 vs [PAP]. Conditions: 0.625-50 µM PAP,
50 mM Tris buffer, pH 8.5, 0.5 mM MgCl2, 5 nM enzyme, 30 °C.
Table 1: Michaelis-Menten Parameters for Rv2131c
substrate Km (µM)
a kcat (s-1)
a kcat/Km (µM-1 min-1)
PAP 8.1 ( 3.1 5.4 ( 1.1 42 ( 8
IMP 7110 ( 1070 0.31 ( 0.13 0.0027 ( 0.0015
FBP 566 ( 107 0.24 ( 0.05 0.025 ( 0.001
a KaleidaGraph (version 4.03) was used to extract Km and kcat from
initial velocity data. Conditions for PAP: 0.625-50 µM PAP, 50 mM
Tris buffer, pH 8.5, 0.5 mM MgCl2, 5 nM enzyme. Conditions for IMP
and FBP: IMP (1-5.5 mM) or FBP (90-900 µM), 50 mM Tris buffer,
pH 9.0, 10 mM MgCl2, 110 nM enzyme. All reactions were performed
at 30 °C. These data represent the average of three independent
experiments.
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In recent years, a framework for mycobacterial sulfur
metabolism has emerged reﬂecting analogous pathways in
E. coli (4, 5, 14). Many key genes of the Cys regulon,
including the cysDNC genes and cysH, have been identiﬁed
and characterized (15, 16, 44, 45). Here, we augment the
current picture of sulfur metabolism in Mtb to include CysQ,
a PAP phosphatase encoded by the RV2131c gene.
Following its identiﬁcation by homology to the E. coli
CysQ, RV2131c was recombinantly expressed and puriﬁed
from E. coli. Biochemical studies of the RV2131c enzyme
revealed its ability to dephosphorylate PAP in a magnesium-
dependent manner that was sensitive to inhibition by lithium,
sodium, and potassium ions. The enzyme exhibited optimal
activity with 0.5 mM MgCl2 at pH 8.5-9.5. A sensitive ESI-
MS assay was used to extract the kinetic parameters for PAP,
which were comparable to those of the E. coli CysQ. PAP
was the substrate utilized most efﬁciently by the enzyme,
which exhibited relatively little activity with IMP and FBP.
Genetic complementation studies in E. coli conﬁrmed its
ability to dephosphorylate PAP and PAPS in ViVo, reafﬁrm-
ing its place in the sulfate assimilation pathway of Mtb.
While the RV2131c enzyme was originally classiﬁed as a
bifunctional inositol monophosphatase and fructose-1,6-
bisphosphatase, our ﬁndings suggest its primary physiological
role relates to mycobacterial sulfur metabolism and not to
the biosynthesis of myo-inositol. By controlling the pools
of PAP and PAPS in the cell, Rv2131c is poised to serve as
a key regulator of the sulfate assimilation pathway. This
enzyme, which we rename CysQ in accordance with its
genomic annotation, has the potential to manipulate sulfation
levels in the cell and control the biosynthesis of essential
reduced sulfur-containing metabolites. Future studies will
investigate the effects of cysQ deletion on sulfation levels
in Mtb and evaluate its importance for bacterial growth and
pathogenesis.
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